India & Dubai, UAE Jan 10, 2026

India faces a persistent protein gap and rising demand for clean, plant-based nutrition. Imported whey and soy dominate the current market, while many consumers report digestive or allergy issues with existing products. Concurrently, plant-protein is a rapidly growing category with an estimated CAGR in double digits, and consumers are seeking locally sourced, low-GI, high-fiber alternatives.

What the Startup Delivers?

Millets Proteins, presented by KSR Group Pvt. Ltd., has developed a millet-based plant protein platform built on India’s ancient supergrains. Product formats include protein powders, RTD shakes, protein bars, and clinical nutrition formulations. The portfolio is lactose-free, designed for easier digestion, and positioned for users across fitness, diabetic care, elderly nutrition, women and children.

Why Now?

Millets combine nutritional advantages high fiber, low glycemic index and mineral density with climate resilience and low water needs. Rising consumer interest in traceable, clean-label ingredients and a national emphasis on crop diversification create favorable timing for a domestically produced plant-protein alternative that reduces reliance on imports.

Program Plan (first 30–60 days)

Under EquityPilot, MILLETS PROTEINS will prioritize: - Manufacturing scale-up planning and pilot production validation - Refining D2C funnel and marketplace listings for initial product SKUs - Regulatory and clinical documentation planning for the clinical nutrition line - Customer segmentation tests targeting fitness users and diabetic cohorts

Proof and Competitive Landscape Millet-based proteins are differentiated by ingredient provenance, digestibility, and environmental footprint. MILLETS PROTEINS’s strengths include Indian sourcing, clean-label formulations and an eco-friendly value proposition. The company aims to convert health-conscious consumers who currently choose imported whey or soy by offering comparable protein content with fewer digestive complaints and a lower environmental cost.

Leadership Comment

Hesham Zreik, Founder and CEO of FasterCapital, said: ‘We’re excited to support MILLETS PROTEINS through EquityPilot. Our team will focus on execution milestones and connecting the startup with the right ecosystem stakeholders.’

Next 90 Days

MILLETS PROTEINS will execute pilot manufacturing, launch a targeted D2C campaign, onboard initial marketplace partners and begin outreach to pharmacy distribution channels. The team will also finalize R&D priorities tied to clinical nutrition formulations and prepare export readiness activities.

Competitive landscape: Category incumbents rely heavily on whey and soy; millet protein presents a category-adjacent opportunity that emphasizes digestive tolerance, traceability and sustainability. - Funding readiness note: MILLETS PROTEINS is raising ₹10–15 Cr to support manufacturing, marketing and R&D initiatives aligned with short-term commercial milestones.

About MILLETS PROTEINS

MILLETS PROTEINS develops millet-based plant protein products that are lactose-free, nutrient-dense and environmentally considerate. Product lines span powders, ready-to-drink shakes, bars and clinical nutrition solutions designed for diverse consumer groups. The company aims to make millets a mainstream protein source in India and beyond.

About FasterCapital

FasterCapital supports startups globally by providing execution-focused support, fundraising readiness guidance, and access to an ecosystem of mentors, partners, and investors. Through programs such as EquityPilot, FasterCapital helps founders strengthen their strategy, refine materials, and accelerate progress toward measurable milestones. Learn more at FasterCapital.